Dose-Dependent Effect of a New Biotin Compound in Hippocampal Remyelination in Rats

Basit Öğe Kaydı
dc.authorid0000-0002-1329-3143
dc.contributor.authorYulug, Burak
dc.contributor.authorKilic, Ertugrul
dc.contributor.authorOguz, Tuba
dc.contributor.authorOrhan, Cemal
dc.contributor.authorEr, Besir
dc.contributor.authorTuzcu, Mehmet
dc.contributor.authorOzercan, Ibrahim Hanifi
dc.date.accessioned2026-01-24T12:31:00Z
dc.date.available2026-01-24T12:31:00Z
dc.date.issued2025
dc.departmentAlanya Alaaddin Keykubat Üniversitesi
dc.description.abstractDemyelination is commonly observed in neurodegenerative disorders, including multiple sclerosis (MS). Biotin supplementation is known to stabilize MS progression. To reduce the effective dose of biotin, we synthesized a new and superior form of biotin, a complex of magnesium ionically bound to biotin (MgB) and compared its dose-dependent effect with biotin alone after inducing demyelination using lysolecithin (LPC) in rats. Myelination was assessed using luxol fast blue staining and immunostaining against MBP protein, revealing that the most significant remyelination occurred in the MgB groups. Additionally, both biotin and MgB-treated animals showed dose-dependent improvements in spatial memory. Moreover, we detected a decrease in inflammatory proteins in both treatment groups, which was more prominent in high-dose MgB-treated animals and correlated with decreased expression of NF-kappa B p65, OP, and MMP-9 proteins. Further analysis of biotin-related proteins demonstrated that both biotin and, notably, MgB reversed the demyelination-dependent reduction of these proteins. Furthermore, biotin, particularly MgB, improved neuronal transmission proteins, Synapsin-1, PSD-93, and PSD-95. Additionally, both treatment groups exhibited increased BDNF, GAP43, and ICAM levels, with significant increments observed in high-dose MgB-treated animals. Increased GFAP, indicative of reactive gliosis, was observed in LPC-treated animals, and this effect was notably reversed by high-dose MgB treatment. The current data emphasize the dose-dependent beneficial effect on the remyelination process. Furthermore, the combination of biotin with Mg resulted in a more potent effect compared to biotin by itself. The strong influence of MgB encourages proof-of-concept studies using MgB in patients with MS.
dc.description.sponsorshipJDS Therapeutics; JDS Therapeutics, LLC (Purchase, NY, USA); Turkish Academy of Sciences
dc.description.sponsorshipThe authors thank JDS Therapeutics, LLC (Purchase, NY, USA) for grant support. This work was partly supported by the Turkish Academy of Sciences (KS and EK).
dc.identifier.doi10.1007/s12035-025-04686-y
dc.identifier.endpage6520
dc.identifier.issn0893-7648
dc.identifier.issn1559-1182
dc.identifier.issue5
dc.identifier.pmid39821844
dc.identifier.scopus2-s2.0-85217234654
dc.identifier.scopusqualityQ1
dc.identifier.startpage6503
dc.identifier.urihttps://doi.org/10.1007/s12035-025-04686-y
dc.identifier.urihttps://hdl.handle.net/20.500.12868/5580
dc.identifier.volume62
dc.identifier.wosWOS:001398676000001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofMolecular Neurobiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260121
dc.subjectBiotin
dc.subjectMagnesium-biotin
dc.subjectDemyelination
dc.subjectMultiple sclerosis
dc.subjectRemyelination
dc.titleDose-Dependent Effect of a New Biotin Compound in Hippocampal Remyelination in Rats
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu